Stockscreener 앱 받기
2.27
5.58%
0.12
Nrx Pharmaceuticals Inc 주식(NRXP)의 최신 뉴스
Patterns Watch: Is NRx Pharmaceuticals Inc a potential multi baggerJuly 2025 Momentum & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
NRXP Stock: Ascendiant Capital Raises Price Target to $48 | NRXP - GuruFocus
Milestone Patient Data Eclipsing 70,000 on Real World Use - openPR.com
NRx Pharmaceuticals Addresses Nasdaq Meeting Compliance Requirements - TipRanks
NRx Pharmaceuticals Received Notice of Noncompliance - TradingView — Track All Markets
NRx Pharmaceuticals Announces 2025 Annual Meeting Date and Record Date - Investing News Network
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date - The Manila Times
Shareholders face Jan. 26 deadline for NRx 2025 meeting proposals - Stock Titan
Sentiment Review: What are NRx Pharmaceuticals Incs recent SEC filings showingPortfolio Return Summary & AI Forecasted Entry/Exit Points - baoquankhu1.vn
NRx Pharmaceuticals Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be submitted to the FDA in Support of NRX-100 Approval - marketscreener.com
Biotech NRx Pharma outlines its business at H.C. Wainwright investor event - Stock Titan
NRx Pharmaceuticals (NASDAQ:NRXP) Given "Buy" Rating at BTIG Research - MarketBeat
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval - Sahm
FinancialContentMilestone Patient Data Eclipsing 70,000 on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) - FinancialContent
NRx Pharmaceuticals (NASDAQ: NRXP) Licenses Real-World Evidence From 70,000 Patients to Support FDA Accelerated Approval of NRX-100 - Digital Journal
NRx Pharmaceuticals Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression - citybiz
NRXP stock slips premarket as NRx says FDA fast-tracked ketamine bid with 70,000-patient dataset - TechStock²
Why Did NRXP Stock Surge 21% Pre-Market Today? - Stocktwits
NRx Pharmaceuticals' NRX-100 Receives FDA Fast Track Designation for Treatment of Suicidal Ideation in Depression and Bipolar Depression - Quiver Quantitative
70,000 patients' ketamine data may help FDA weigh suicide therapy - Stock Titan
Is NRx Pharmaceuticals Inc backed by strong institutional buying2025 Sector Review & Verified Stock Trade Ideas - baoquankhu1.vn
Earnings Report: Should I hold or sell NRx Pharmaceuticals Inc Equity Warrant stock in 2025Quarterly Trade Review & Daily Oversold Bounce Ideas - Bộ Nội Vụ
Retail Surge: Whats the beta of NRx Pharmaceuticals Inc stockWeekly Trade Report & Stepwise Swing Trade Plans - baoquankhu1.vn
Published on: 2026-01-11 15:15:08 - ulpravda.ru
How institutional buying supports NRx Pharmaceuticals Inc. Equity Warrant stockJuly 2025 Sentiment & High Return Trade Guides - Улправда
Why NRx Pharmaceuticals Inc. Equity Warrant stock remains a top recommendationJuly 2025 Closing Moves & Fast Exit Strategy with Risk Control - ulpravda.ru
Will NRx Pharmaceuticals Inc. Equity Warrant stock rally after Fed decisionsAnalyst Upgrade & Verified Technical Signals - ulpravda.ru
Why NRx Pharmaceuticals Inc. Equity Warrant stock appeals to dividend seekersWeekly Investment Recap & Risk Managed Investment Strategies - Улправда
Can NRx Pharmaceuticals Inc. stock withstand economic slowdownWeekly Market Report & Technical Entry and Exit Alerts - ulpravda.ru
Will NRx Pharmaceuticals Inc. Equity Warrant stock outperform value stocksWeekly Earnings Recap & Consistent Profit Trading Strategies - ulpravda.ru
Market Recap: Is NRx Pharmaceuticals Inc. Equity Warrant stock in correction or buying zoneJuly 2025 Earnings & Safe Capital Allocation Plans - ulpravda.ru
PRN_FinancialWrapper | PR NewswireNRX Pharmaceuticals, Inc.Warrant (Nasdaq:NRXPW) Stock Quote - FinancialContent
Can NRx Pharmaceuticals Inc. stock beat market expectations this quarterWeekly Risk Report & Daily Chart Pattern Signal Reports - ulpravda.ru
NRX Pharmaceuticals, Inc.Common Stock (NQ: NRXP - FinancialContent
Why NRx Pharmaceuticals Inc. Equity Warrant stock attracts global investorsLow Beta Stocks & Start Your Free Trading Journey Today - ulpravda.ru
NRXP SEC FilingsNrx Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
A High-Stakes Alliance Aims to Standardize Mental Health Care at Scale - MyChesCo
NRx and neurocare partner to create nationwide neuroplastic care network By Investing.com - Investing.com Nigeria
Will NRx Pharmaceuticals Inc. Equity Warrant stock reach all time highs in 20252026 world cup usa national team semifinals star players set piece tactics odds analysis preview - ulpravda.ru
NRx Pharmaceuticals (NASDAQ: NRXP) Partners With neurocare Group AG To Build Nationwide Neuroplastic Care Network - Digital Journal
NRx Pharmaceuticals and neurocare group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and Other Mental Health Afflictions - citybiz
About Us - FinancialContent
D. Boral Capital Reaffirms "Buy" Rating for NRx Pharmaceuticals (NASDAQ:NRXP) - MarketBeat
NRx Pharmaceuticals and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions - Investing News Network
NRx and neurocare partner to create nationwide neuroplastic care network - Investing.com
NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions - The Manila Times
NRx Pharmaceuticals and neurocare Group AG Launch Integrated Nationwide Network for Neuroplastic Therapy to Combat Depression and PTSD - Quiver Quantitative
NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG - GlobeNewswire
Ulta Beauty To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
Breakout Zone: Is NRx Pharmaceuticals Inc Equity Warrant stock in correction or buying zone2025 Growth vs Value & Safe Entry Trade Signal Reports - moha.gov.vn
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
NRx Pharmaceuticals Completes Debt Repayment, Ends 2025 Debt-Free - The Globe and Mail
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Short Interest Up 38.2% in December - MarketBeat
NRX Pharmaceuticals, Inc. Eliminates All Balance Sheet Debt - TradingView — Track All Markets
New to The Street's Prestigious Client NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free Ketamine - Sentinel-Standard
NRx’s preservative-free ketamine reaches FDA review as company targets 2026 launch - MSN
New to The Street Broadcasts Nationwide Tonight on Bloomberg Television Featuring NeOnc ($NTHI), Metaterra Holdings Inc., CISO Global ($CISO), and NRx Pharmaceuticals ($NRXP) - Idaho Statesman
Earnings Update: Why hedge funds are buying NRx Pharmaceuticals Inc. stockPortfolio Update Summary & Risk Controlled Swing Trade Alerts - moha.gov.vn
NRX Pharmaceuticals Earnings Notes - Trefis
Bearish Setup: Will NRx Pharmaceuticals Inc. Equity Warrant stock outperform value stocksJuly 2025 Opening Moves & Daily Volume Surge Signals - moha.gov.vn
Is NRx Pharmaceuticals Inc. stock a top momentum play2025 Buyback Activity & Safe Capital Investment Plans - ulpravda.ru
Will NRx Pharmaceuticals Inc. stock pay special dividends2025 Retail Activity & Low Drawdown Momentum Ideas - Улправда
Published on: 2025-12-19 15:23:52 - DonanımHaber
4.73%
0.92%
자본화:
|
볼륨(24시간):